Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
75 participants
OBSERVATIONAL
2021-06-15
2023-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Chronic Obstructive Pulmonary Disease (COPD) Biomarker Identification Study
NCT01780298
Biomarkers of Early Chronic Obstructive Pulmonary Disease (COPD) in Smokers - Longitudinal Study
NCT02076061
Markers for Chronic Obstructive Pulmonary Disease (COPD)
NCT00180622
Biological Markers for Professional COPD
NCT03240198
Lung Health of Early COPD: A Multi-center Cohort Study
NCT05466396
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
frequent exacerbation patients
Physical examinations
BPCO physical examinations
blood test
blood test in order to study immunologic markers
non frequent exacerbation patients
Physical examinations
BPCO physical examinations
blood test
blood test in order to study immunologic markers
Asthma-and-COPD overlap syndrome
Physical examinations
BPCO physical examinations
blood test
blood test in order to study immunologic markers
Asthmatic patients (without COPD)
Physical examinations
BPCO physical examinations
blood test
blood test in order to study immunologic markers
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Physical examinations
BPCO physical examinations
blood test
blood test in order to study immunologic markers
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ACOS patients
* asthmatic patient without BPCO
Exclusion Criteria
* exacerbation
* immunosuppressive treatment
* immunosuppressive disease
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire, Amiens
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Amiens
Amiens, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PI2021_843_0051
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.